GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the human BETA2 adrenergic receptor in complex with a novel inverse agonist

Analyse Crystal structure of the human BETA2 adrenergic receptor in complex with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3NY9
Type
protein
Length
439 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-2 adrenergic receptor, lysozyme
UniProt
P07550, P00720
Ligands
CLR, JSZ
Pockets
4 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-2 adrenergic receptor, lysozymeprotein43975% helix, 3% strandP07550, P00720

Ligands and binding sites

  • CLR · Cholesterol · ligand · 2 copies · chains A
  • JSZ · ethyl 4-({(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)-3-methyl-1-benzofuran-2-carboxylate · ligand · chains A
  • OLC · (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14560.790.8753JSZ
22560.640.8224empty
32010.500.7627empty
41660.470.7618empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3NY9 · Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse… · the same entry in another collection · chain A against A, TM-score 1.00
  • P07550 · AlphaFold monomer V2.0 prediction for beta-2 adrenergic receptor (P07550) · a predicted model of the same protein · chain A against A, TM-score 0.66

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.